NantHealth Acquires OpenNMS, the World’s Largest Open Source Network Management Application Platform

CULVER CITY, Calif.–()–NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalised healthcare firm, right this moment introduced the acquisition of The OpenNMS Group, Inc. (www.opennms.com), the world’s premier open-source community administration firm, which is able to function as a subsidiary of NantHealth. The transaction closed on July 22, 2020.

“OpenNMS has set the standard for open-source network monitoring since 2000 with its enterprise-grade network management platform,” stated Ron Louks, Chief Operating Officer, NantHealth. “We are thrilled to have them be part of the NantHealth household.

“This acquisition not only expands and diversifies NantHealth’s software portfolio and service offerings, but it expands our company-wide capabilities in cloud, SaaS and AI technologies. OpenNMS, we believe, will provide our customers with a new world class set of services to maintain reliable network connections for critical data flows that enable patient data collaboration and decision making at the point of care.”

Based in Morrisville, NC, OpenNMS offers a extremely dependable, scalable and complete fault, efficiency and visitors monitoring answer that simply integrates with enterprise purposes and workflows to watch and visualize every part in a community. The OpenNMS platform screens a few of the largest networks in existence, overlaying the healthcare, expertise, finance, authorities, schooling, retail and industrial sectors, many with tens of hundreds of networked units. OpenNMS clients embody three of the highest 5 corporations on the Fortune 100, in addition to a number of giant and multi-state well being suppliers and one of many largest digital medical report suppliers within the United States.

“I’m delighted for our organization to join the talented team of software and artificial intelligence engineers at NantHealth, which will enable OpenNMS to accelerate our adoption of machine learning and data science technologies,” stated David Hustace, CEO of OpenNMS. “This transaction strengthens our internal capabilities as we move to offer SaaS-based solutions to our customers across all industries, while also expanding our penetration in the healthcare industry.”

The OpenNMS platform offers key insights and analytics relating to community efficiency and availability wanted for organizations to take care of uptime throughout a number of environments, geographies and units. Platform options embody:

  • Event Management. OpenNMS can function the central repository and correlation system for system logs and notifications from all units on a community.
  • Fault Management. OpenNMS actively screens latency and exams the supply of all units on a community utilizing over 30 completely different protocols as artificial transactions, that are additional analyzed by distinctive machine and deep studying applied sciences imbedded in its Architecture for Learning Enabled Correlation (ALEC).
  • Performance Measurement. OpenNMS can accumulate and obtain streams of telemetry (time-series) information from units on a community through a number of protocols: HTTP, SNMP, JMX, WMI/ws-man, gRPC, gpb over UDP. This information could be saved, graphed and measured for thresholds and streamed to Kafka for integration with different enterprise techniques.
  • Traffic Management. OpenNMS offers a extremely scalable answer for actively monitoring and correlating community flows together with its fault and efficiency information.

OpenNMS is continuous to increase its best-in-industry reliability and scalability by creation of cloud options and providers, implementation of {hardware} home equipment for growth of edge monitoring, continued funding in its AI/ML enabled ALEC answer, and addition of superior route monitoring options driving extra information for ALEC.

About NantHealth

NantHealth, a member of the NantWorks ecosystem of corporations, offers main options throughout the continuum of take care of physicians, payers, sufferers and biopharmaceutical organizations. NantHealth permits using cutting-edge information and expertise towards the objectives of empowering medical determination assist and enhancing affected person outcomes. NantHealth’s complete product portfolio combines the newest expertise in payer/supplier platforms that change info in near-real time (NaviNet and Eviti), and molecular profiling providers that mix complete DNA & RNA tumor-normal profiling with pharmacogenomics evaluation (GPS Cancer®). For extra info, please go to www.nanthealth.com or comply with us on Twitter, Facebook and LinkedIn.

Forward-Looking Statements

This information launch accommodates sure statements of a forward-looking nature referring to future occasions or future enterprise efficiency. Forward-looking statements could be recognized by the phrases “expects,” “anticipates,” “believes,” “intends,” “estimates,” “plans,” “will,” “outlook” and comparable expressions. Forward-looking statements are based mostly on administration’s present plans, estimates, assumptions and projections, and converse solely as of the date they’re made. Risks and uncertainties embody, however will not be restricted to: our potential to efficiently combine a fancy studying system to deal with a variety of healthcare points; our potential to efficiently amass the requisite information to attain most community results; appropriately allocating monetary and human sources throughout a broad array of product and repair choices; elevating further capital as essential to fund our operations; reaching important business market acceptance for our sequencing and molecular evaluation options; set up relationships with, key thought leaders or payers’ key determination makers so as to set up GPS Cancer as a regular of take care of sufferers with most cancers; our potential to develop the marketplace for our Systems Infrastructure, and purposes; efficiently enhancing our Systems Infrastructure and purposes to attain market acceptance and preserve tempo with technological developments; buyer focus; competitors; safety breaches; bandwidth limitations; our potential to proceed our relationship with NantOmics; our potential to acquire regulatory approvals; dependence upon senior administration; the necessity to adjust to and meet relevant legal guidelines and rules; surprising adversarial occasions; medical adoption and market acceptance of GPS Cancer; and anticipated price financial savings. We undertake no obligation to replace any forward-looking assertion in mild of recent info or future occasions, besides as in any other case required by legislation. Forward-looking statements contain inherent dangers and uncertainties, most of that are troublesome to foretell and are usually past our management. Actual outcomes or outcomes might differ materially from these implied by the forward-looking statements on account of the influence of quite a few elements, a lot of that are mentioned in additional element in our reviews filed with the Securities and Exchange Commission.

LEAVE A REPLY

Please enter your comment!
Please enter your name here